Home/Filings/4/0001493152-23-038573
4//SEC Filing

Mohan Pankaj 4

Accession 0001493152-23-038573

CIK 0001106838other

Filed

Oct 26, 8:00 PM ET

Accepted

Oct 27, 8:00 PM ET

Size

9.3 KB

Accession

0001493152-23-038573

Insider Transaction Report

Form 4
Period: 2023-10-27
Mohan Pankaj
DirectorChairman, President and CEO
Transactions
  • Purchase

    Common Stock

    2023-10-27+34,37559,526 total
  • Purchase

    Warrant to Purchase Common Stock

    2023-10-27+68,75068,750 total
    Exercise: $1.60From: 2023-10-27Exp: 2028-10-27Common Stock (68,750 underlying)
Holdings
  • Common Stock

    (indirect: By Mohan Family Office)
    3,021
  • Common Stock

    (indirect: By Children)
    25
Footnotes (4)
  • [F1]Reporting Person purchased 34,375 shares of common stock and 68,750 warrants to purchase 68,750 shares of common stock pursuant to an underwritten public offering by the Issuer at $1.60 per share and accompanying two warrants. The offering closed on October 27, 2023.
  • [F2]Includes unvested restricted stock units.
  • [F3]All amounts reflect the 1:22 reverse stock split effective as of August 31, 2023.
  • [F4]Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.

Documents

1 file

Issuer

Sonnet BioTherapeutics Holdings, Inc.

CIK 0001106838

Entity typeother

Related Parties

1
  • filerCIK 0001664386

Filing Metadata

Form type
4
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 8:00 PM ET
Size
9.3 KB